Back to Search
NETTIE IRWIN, MD
Pediatrics Physician
NPI: 1801475314Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
12974710-1205(UT)228059(AK)
Research & Publications (20)
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intolerance.
PMID 19026698·Peptides·2009
7-preclinical
Active immunisation against gastric inhibitory polypeptide (GIP) improves blood glucose control in an animal model of obesity-diabetes.
PMID 18937625·Biol Chem·2009
7-preclinical
Antidiabetic effects of sub-chronic activation of the GIP receptor alone and in combination with background exendin-4 therapy in high fat fed mice.
PMID 19073224·Regul Pept·2009
7-preclinical
Variation in phenotype, parasite load and male competitive ability across a cryptic hybrid zone.
PMID 19479073·PLoS One·2009
7-preclinical
Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice.
PMID 19515180·Diabetes Obes Metab·2009
4-observational
Fatty acid derivatised analogues of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
PMID 19523458·Biochem Pharmacol·2009
7-preclinical
Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications.
PMID 19533083·Diabetologia·2009
6-review
Inosine alters gene expression and axonal projections in neurons contralateral to a cortical infarct and improves skilled use of the impaired limb.
PMID 19553458·J Neurosci·2009
7-preclinical
Comparison of independent and combined chronic metabolic effects of GIP and CB1 receptor blockade in high-fat fed mice.
PMID 18291559·Peptides·2008
4-observational
C-terminal mini-PEGylation of glucose-dependent insulinotropic polypeptide exhibits metabolic stability and improved glucose homeostasis in dietary-induced diabetes.
PMID 18455149·Biochem Pharmacol·2008
7-preclinical
Daily administration of the GIP-R antagonist (Pro3)GIP in streptozotocin-induced diabetes suggests that insulin-dependent mechanisms are critical to anti-obesity-diabetes actions of (Pro3)GIP.
PMID 18333892·Diabetes Obes Metab·2008
4-observational
Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity.
PMID 18225986·Biol Chem·2008
7-preclinical
Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice.
PMID 18191122·Eur J Pharmacol·2008
7-preclinical
Effects of gastric inhibitory polypeptide (GIP) and related analogues on glucagon release at normo- and hyperglycaemia in Wistar rats and isolated islets.
PMID 18163884·Biol Chem·2008
7-preclinical
Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1.
PMID 18184314·Eur J Neurosci·2008
7-preclinical
(Pro(3))GIP[mPEG]: novel, long-acting, mPEGylated antagonist of gastric inhibitory polypeptide for obesity-diabetes (diabesity) therapy.
PMID 18695644·Br J Pharmacol·2008
7-preclinical
Long-term administration of antisense oligonucleotides into the paraspinal muscles of mdx mice reduces kyphosis.
PMID 18499783·J Appl Physiol (1985)·2008
7-preclinical
Metabolic effects of sub-chronic ablation of the incretin receptors by daily administration of (Pro3)GIP and exendin(9-39)amide in obese diabetic (ob/ob) mice.
PMID 17261085·Biol Chem·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1650 COWLES ST
FAIRBANKS, AK 99701 - Phone
- (907) 459-3520
Quick Facts
- NPI
- 1801475314
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile